Thu, Jan 29, 2015, 11:28 AM EST - U.S. Markets close in 4 hrs 32 mins


% | $
Quotes you view appear here for quick access.

Apricus Biosciences, Inc. Message Board

  • court.fool2000 court.fool2000 Apr 1, 2013 5:08 PM Flag


    On March 18th, Apricus released its 2012 10-K and corporate update. As of December 31st, the company had cash and equivalents of approximately $15.1 million. Hidden in the filing was a bit of information that had not been announced in 2013. In March Apricus closed the sale of its New Jersey manufacturing facility, resulting in proceeds of $3.6 million. This cash infusion gives the company a bit more breathing room financially, but it still expects to need external financing to complete its long-term goals. According to the filing, Apricus now has cash sufficient to fund its operations for another 12 months, so I would expect some type of dilutive offering in late 2013 or early 2014, depending on the amount of money received from its oncology support unit sales. With two S-3's currently filed through the SEC, and one of them being an "at the market" (ATM) for $17 million, the possiblity of this vehicle being used on any significant share price spikes in the interim is certainly real and should even be expected.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.4401+0.1101(+8.28%)11:27 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.